Hahn said the changes the agency will keep include a greater focus on decentralized clinical trials, ramping up laboratory-developed tests and increasing the use of telemedicine technology.
The FDA said it also is pivoting toward the use of real-world evidence to monitor medical products amid the pandemic.
More articles on pharmacy:
American Pharmacists Association swears in new CEO
5 recent CMS pharmacy policy changes
Eli Lilly testing COVID-19 drug derived from survivor blood
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.